3-HO-PCE: Difference between revisions
>Unity Added missing citation. |
>Unity Restructuring for readability. |
||
Line 19: | Line 19: | ||
While no formal studies have been conducted, 3-HO-PCE likely acts principally as an [[NMDA receptor antagonist]].<ref name="3HOPCEsar" /> | While no formal studies have been conducted, 3-HO-PCE likely acts principally as an [[NMDA receptor antagonist]].<ref name="3HOPCEsar" /> | ||
The NMDA (N-Methyl-D-Aspartate) receptor, specific subtype of [[glutamate]] receptor, modulates the transmission of electrical signals between neurons in the brain and spinal cord; for the signals to pass, the receptor must be open. | |||
Dissociatives inhibit the normal functioning NMDA receptors by binding to and blocking them. This disruption of neural network activity leads to loss of normal cognitive and affective processing, psychomotor functioning, anesthesia.{{citation needed}} | |||
There is ongoing speculation as to whether this compound displays [[μ-opioid]] receptor activity due to its structural relationship to 3-HO-PCP, which has been found to have appreciable affinity as a [[μ-opioid]] [[receptor]] [[agonist]] in animal models.<ref name="3HOPCEsar" /> | There is ongoing speculation as to whether this compound displays [[μ-opioid]] receptor activity due to its structural relationship to 3-HO-PCP, which has been found to have appreciable affinity as a [[μ-opioid]] [[receptor]] [[agonist]] in animal models.<ref name="3HOPCEsar" /> |